RICHLAND, Wash. — A new study of an exotic, infectious virus that has caused three recent outbreaks in the United States reveals clues to how the virus might damage lungs during infection. The findings also suggest possible new ways to treat lu…
Philadelphia, PA, October 14, 2010 — Fibromyalgia (FM) is a debilitating condition affecting 11 million individuals in the US alone. FM carries an annual direct cost for care of more than $20 billion and drug therapies are generally only …
PORTLAND, Ore — According to new research conducted at Oregon Health & Science University, yoga exercises may have the power to combat fibromyalgia — a medical disorder characterized by chronic widespread pain. The research is being published …
PORTLAND, Ore. — Using MRI technology and mathematical analysis, researchers at Oregon Health & Science University and Washington University in St. Louis are now able to accurately predict a young person’s age simply by studying their brain scans…
PORTLAND, Ore. — A study led by researchers in the Oregon Health & Science University Smoking Cessation Center may change the way clinicians make treatment decisions for their patients who smoke.
Their findings published online in the journal …
Researchers have explained how adult stem cells can heal diseased liver tissue. The research helps direct scientists in the quest for therapeutic uses of adult stem cells, which are derived from bone marrow. The research may also help define the therapeutic limits of these stem cells.
Drugs commonly prescribed to osteoporosis and cancer patients may also cause serious ocular side effects in some cases. That’s the conclusion of a study published today by scientists at the Oregon Health & Science University Casey Eye Institute. This research is expected to alert physicians to monitor patients for eye problems not previously associated with the drug. The announcement may also help physicians identify problems earlier, therefore preventing long-term sight damage. Finally, this finding may prompt drug companies to update their product labeling, forewarning physicians and users.
Researchers have identified a key hormone involved in appetite control and demonstrated its effect on the brain. Scientists have shown that the hormone, called ghrelin, activates specialized neurons in the hypothalamus involved in weight regulation. Researchers believe this information could be used to develop drugs aimed at stimulating appetite in patients who have undergone extreme weight loss due to illness, a condition known as cachexia. Conversely, drugs aimed at limiting production of the hormone might be developed to reduce appetite for those battling severe obesity.
Amid the glowing results for chronic myelogenous leukemia (CML) patients using Gleevec the past three years, the one reality check has been that a majority of the patients with advanced disease eventually relapse and die of the leukemia. An article to be published in the Dec. 15 issue of the journal Cancer Research shows that, in the lab, the molecular mutations that produce a resistance to Gleevec can be overcome. Brian Druker, M.D., Howard Hughes Medical Institute Investigator and JELD-WEN Chair of Leukemia Research at the Oregon Health & Science University Cancer Institute, and colleagues report that a compound called PD180970 successfully stopped the activity of several mutations found in patients who developed a resistance to Gleevec.